Kalohexis
PrivateCompany Overview
Kalohexis operates in Healthcare & Life Sciences and is based in Northbrook, Illinois. It was founded in 2026.
Kalohexis is a clinical-stage biotechnology company that develops treatments for metabolic disorders such as obesity and cancer cachexia by harnessing the melanocortin system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kalohexis Comparables
Compare Kalohexis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Endevica Bio | 85% | |
| Courage Therapeutics | 82% | |
| Kailera Therapeutics | 68% |
For institutional investors. Book with your work email.
Kalohexis Funding Rounds
Historical fundraising activity
Recent news
Latest coverage and updates
- hiresAug 11, 2026
Kalohexis appoints life sciences leader Jeffrey Sherman, MD, to its Board of Directors in Illinois on Aug 11th '26; he brings more than 35 years of pharmaceutical experience, including service as chief medical officer of Horizon Therapeutics.
For institutional investors. Book with your work email.
Kalohexis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kalohexis's valuation, stock price, and market status.
Is Kalohexis a public or private company?
Kalohexis is a private company.
What is the current stock price of Kalohexis?
Kalohexis is a private company, so its shares have no public market price. Caplight tracks Kalohexis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kalohexis worth (valuation)?
Valuation information for Kalohexis is not publicly available.
Can I buy Kalohexis stock?
Kalohexis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kalohexis's last funding round?
Funding round information for Kalohexis is not publicly available.
Who are the main investors in Kalohexis?
Investor information for Kalohexis is not publicly disclosed.
Will Kalohexis IPO soon?
No public IPO plans have been announced for Kalohexis.
How can I track Kalohexis secondary market activity?
Caplight tracks bids, offers, and trades in Kalohexis's shares on secondary markets.